Lotus Clinical Research Expands Partnership with Veeva to Accelerate Clinical TrialsFast-growing CRO utilizes Veeva Vault Clinical Suite to substantially decrease startup timeNEW PROVIDENCE, NJ and BARCELONA, Spain — 30 May 2023 — Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research ex.
Michael Nieves had been waiting for trial for three years, circling eight times through worn-out revolving doors between the city’s jails and psychiatric facilities. His saga illustrates a profound weakness in the city’s criminal justice system when it comes to handling people with psychiatric disorders and the devastating consequences of that shortcoming.
Los Angeles (PRWEB) October 27, 2021 BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout
/PRNewswire/ Sponsors and contract research organizations (CROs) are accelerating digital transformation to advance toward patient-centric, paperless, and.